Pain Management Drugs and Devices - Global Market Outlook (2017-2023)

Pain Management Drugs and Devices - Global Market Outlook (2017-2023)

  • Published: January 2018
  • ID: SMRC16950

According to Stratistics MRC, the Global Pain Management Drugs and Devices Market is accounted for $41.73 billion in 2016 and is expected to reach $61.52 billion by 2023 growing at a CAGR of 5.7% during the forecast period. Growing healthcare industry across the globe, rapid technological developments and increasing various pain disorders tied with rising global geriatric people are some of the key factors propelling the market growth. However, factors such as availability of alternative therapies, drug abuse and patent expiration of prescription drugs are hindering the market.

Neuromodulation is technology that is used for the alteration or modulation of the nerve activity by using chemical agents or electrical stimulation to the specific neurological sites in the body. Most of the neuromodulation devices work through electrical stimulation. Neuromodulation devices are used by the application of electrodes to the brain, peripheral nerves or the spinal cord. The electrode leads in neuromodulation devices are connected through an extension cable to a power source and pulse generator, which generates required electrical impulses. North America is anticipated to hold the largest market share due to the rising incidence of chronic diseases, increasing government support, growing middle-class population and disposable income levels in this region.

Some of the key players in the Pain Management Drugs and Devices Market include Abbott Laboratories, Endo International, Abbvie, DJO Global Inc., Johnson & Johnson, Novartis International AG, Grunenthal Gmbh, ELI Lilly & Co, Hisamitsu Pharmaceutical Co. Inc., Pfizer Inc., Astrazeneca Plc, Purdue Pharma LP, Glaxosmithkline, Medtronic and Boston Scientific Corp.

Device Types Covered:
• Neuromodulation Devices
• Analgesic Infusion Pumps 
• Ablation Devices
• Electrical stimulation devices

Drug Classes Covered:
• Non-Narcotic Analgesics
• Narcotic Pain Management
• Opioids   
• Antidepressent 
• Anesthetics 
• NSAIDS   
• Anticovulsants 
• Anti-Migraine Agents
• Other Drug Classes
 
Applications Covered:
• General Pain
• Dental Pain
• HIV/AIDS Pain
• Migraine Pain
• Orthopedic/Musculoskeletal Pain
• Neuropathic Pain
• Cancer Pain
• Fibromyalgia Pain
• Surgical Pain
• Other Applications

Indications Covered:
• Arthritic Pain
• Chronic back pain

Mode of Purchases Covered:
• Over-the-counter Devices
• Over-the-counter Devices

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan       
    • China       
    • India       
    • Australia 
    • New Zealand     
    • South Korea      
    • Rest of Asia Pacific   
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

1 Executive Summary    
      
2 Preface 
    
 2.1 Abstract    
 2.2 Stake Holders   
 2.3 Research Scope   
 2.4 Research Methodology  
  2.4.1 Data Mining  
  2.4.2 Data Analysis  
  2.4.3 Data Validation  
  2.4.4 Research Approach  
 2.5 Research Sources   
  2.5.1 Primary Research Sources 
  2.5.2 Secondary Research Sources 
  2.5.3 Assumptions  
      
3 Market Trend Analysis   
 3.1 Introduction   
 3.2 Drivers    
 3.3 Restraints   
 3.4 Opportunities   
 3.5 Threats    
 3.6 Application Analysis  
 3.7 Emerging Markets   
 3.8 Futuristic Market Scenario  
      
4 Porters Five Force Analysis   
 4.1 Bargaining power of suppliers  
 4.2 Bargaining power of buyers  
 4.3 Threat of substitutes  
 4.4 Threat of new entrants  
 4.5 Competitive rivalry   
      
5 Global Pain Management Drugs and Devices Market, By Device Type
 5.1 Introduction   
 5.2 Neuromodulation Devices  
  5.2.1 Spinal Cord Stimulation (SCS) Devices
  5.2.2 Sacral Nerve Stimulation Devices
  5.2.3 Vagus Nerve Stimulation Devices
  5.2.4 Deep Brain Stimulation Devices
 5.3 Analgesic Infusion Pumps  
  5.3.1 Intrathecal Infusion Pumps 
  5.3.2 External Infusion Pumps 
 5.4 Ablation Devices   
  5.4.1 Radiofrequency Ablation Devices
  5.4.2 Cryoablation Devices 
 5.5 Electrical stimulation devices  
  5.5.1 Transcutaneous Electrical Nerve Stimulation (TENS) Devices
  5.5.2 Neuromuscular Electrical Stimulation (NMES/EMS) Devices
  5.5.3 Other Electrical Stimulation Devices
      
6 Global Pain Management Drugs and Devices Market, By Drug Classes
 6.1 Introduction   
 6.2 Non-Narcotic Analgesics  
 6.3 Narcotic Pain Management  
 6.4 Opioids      
 6.5 Antidepressent    
 6.6 Anesthetics    
 6.7 NSAIDS      
 6.8 Anticovulsants    
 6.9 Anti-Migraine Agents  
 6.10 Other Drug Classes   
      
7 Global Pain Management Drugs and Devices Market, By Application
 7.1 Introduction   
 7.2 General Pain   
 7.3 Dental Pain   
 7.4 HIV/AIDS Pain   
 7.5 Migraine Pain   
 7.6 Orthopedic/Musculoskeletal Pain 
 7.7 Neuropathic Pain   
 7.8 Cancer Pain   
 7.9 Fibromyalgia Pain   
 7.10 Surgical Pain   
 7.11 Other Applications   
      
8 Global Pain Management Drugs and Devices Market, By Indication
 8.1 Introduction   
 8.2 Arthritic Pain   
 8.3 Chronic back pain   
      
9 Global Pain Management Drugs and Devices Market, By Mode of Purchase
 9.1 Introduction   
 9.2 Over-the-counter Devices  
 9.3 Prescription-based Devices  
      
10 Global Pain Management Drugs and Devices Market, By Geography
 10.1 Introduction   
 10.2 North America   
  10.2.1 US   
  10.2.2 Canada   
  10.2.3 Mexico   
 10.3 Europe    
  10.3.1 Germany   
  10.3.2 UK   
  10.3.3 Italy   
  10.3.4 France   
  10.3.5 Spain   
  10.3.6 Rest of Europe  
 10.4 Asia Pacific   
  10.4.1 Japan   
  10.4.2 China   
  10.4.3 India   
  10.4.4 Australia   
  10.4.5 New Zealand  
  10.4.6 South Korea  
  10.4.7 Rest of Asia Pacific  
 10.5 South America   
  10.5.1 Argentina  
  10.5.2 Brazil   
  10.5.3 Chile   
  10.5.4 Rest of South America 
 10.6 Middle East & Africa  
  10.6.1 Saudi Arabia  
  10.6.2 UAE   
  10.6.3 Qatar   
  10.6.4 South Africa  
  10.6.5 Rest of Middle East & Africa 
      
11 Key Developments    
 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
 11.2 Acquisitions & Mergers  
 11.3 New Product Launch  
 11.4 Expansions   
 11.5 Other Key Strategies  
      
12 Company Profiling    
 12.1 Abbott Laboratories   
 12.2 Endo International   
 12.3 Abbvie    
 12.4 DJO Global Inc.   
 12.5 Johnson & Johnson   
 12.6 Novartis International AG  
 12.7 Grunenthal Gmbh   
 12.8 ELI Lilly & Co.   
 12.9 Hisamitsu Pharmaceutical Co. Inc. 
 12.10 Pfizer Inc.   
 12.11 Astrazeneca Plc   
 12.12 Purdue Pharma LP   
 12.13 Glaxosmithkline   
 12.14 Medtronic   
 12.15 Boston Scientific Corp  


List of Tables     
1 Global Pain Management Drugs and Devices Market Outlook, By Region (2014-2023) (US $MN)
2 Global Pain Management Drugs and Devices Market Outlook, By Device Type (2014-2023) (US $MN)
3 Global Pain Management Drugs and Devices Market Outlook, By Neuromodulation Devices (2014-2023) (US $MN)
4 Global Pain Management Drugs and Devices Market Outlook, By Spinal Cord Stimulation (SCS) Devices (2014-2023) (US $MN)
5 Global Pain Management Drugs and Devices Market Outlook, By Sacral Nerve Stimulation Devices (2014-2023) (US $MN)
6 Global Pain Management Drugs and Devices Market Outlook, By Vagus Nerve Stimulation Devices (2014-2023) (US $MN)
7 Global Pain Management Drugs and Devices Market Outlook, By Deep Brain Stimulation Devices (2014-2023) (US $MN)
8 Global Pain Management Drugs and Devices Market Outlook, By Analgesic Infusion Pumps (2014-2023) (US $MN)
9 Global Pain Management Drugs and Devices Market Outlook, By Intrathecal Infusion Pumps (2014-2023) (US $MN)
10 Global Pain Management Drugs and Devices Market Outlook, By External Infusion Pumps (2014-2023) (US $MN)
11 Global Pain Management Drugs and Devices Market Outlook, By Ablation Devices (2014-2023) (US $MN)
12 Global Pain Management Drugs and Devices Market Outlook, By Radiofrequency Ablation Devices (2014-2023) (US $MN)
13 Global Pain Management Drugs and Devices Market Outlook, By Cryoablation Devices (2014-2023) (US $MN)
14 Global Pain Management Drugs and Devices Market Outlook, By Electrical stimulation devices (2014-2023) (US $MN)
15 Global Pain Management Drugs and Devices Market Outlook, By Transcutaneous Electrical Nerve Stimulation (TENS) Devices (2014-2023) (US $MN)
16 Global Pain Management Drugs and Devices Market Outlook, By Neuromuscular Electrical Stimulation (NMES/EMS) Devices (2014-2023) (US $MN)
17 Global Pain Management Drugs and Devices Market Outlook, By Other Electrical Stimulation Devices (2014-2023) (US $MN)
18 Global Pain Management Drugs and Devices Market Outlook, By Drug Classes (2014-2023) (US $MN)
19 Global Pain Management Drugs and Devices Market Outlook, By Non-Narcotic Analgesics (2014-2023) (US $MN)
20 Global Pain Management Drugs and Devices Market Outlook, By Narcotic Pain Management (2014-2023) (US $MN)
21 Global Pain Management Drugs and Devices Market Outlook, By Opioids (2014-2023) (US $MN)
22 Global Pain Management Drugs and Devices Market Outlook, By Antidepressent (2014-2023) (US $MN)
23 Global Pain Management Drugs and Devices Market Outlook, By Anesthetics (2014-2023) (US $MN)
24 Global Pain Management Drugs and Devices Market Outlook, By NSAIDS (2014-2023) (US $MN)
25 Global Pain Management Drugs and Devices Market Outlook, By Anticovulsants (2014-2023) (US $MN)
26 Global Pain Management Drugs and Devices Market Outlook, By Anti-Migraine Agents (2014-2023) (US $MN)
27 Global Pain Management Drugs and Devices Market Outlook, By Other Drugs Classes (2014-2023) (US $MN)
28 Global Pain Management Drugs and Devices Market Outlook, By Application (2014-2023) (US $MN)
29 Global Pain Management Drugs and Devices Market Outlook, By General Pain (2014-2023) (US $MN)
30 Global Pain Management Drugs and Devices Market Outlook, By Dental Pain (2014-2023) (US $MN)
31 Global Pain Management Drugs and Devices Market Outlook, By HIV/AIDS Pain (2014-2023) (US $MN)
32 Global Pain Management Drugs and Devices Market Outlook, By Migraine Pain (2014-2023) (US $MN)
33 Global Pain Management Drugs and Devices Market Outlook, By Orthopedic/Musculoskeletal Pain (2014-2023) (US $MN)
34 Global Pain Management Drugs and Devices Market Outlook, By Neuropathic Pain (2014-2023) (US $MN)
35 Global Pain Management Drugs and Devices Market Outlook, By Cancer Pain (2014-2023) (US $MN)
36 Global Pain Management Drugs and Devices Market Outlook, By Fibromyalgia Pain (2014-2023) (US $MN)
37 Global Pain Management Drugs and Devices Market Outlook, By Surgical Pain (2014-2023) (US $MN)
38 Global Pain Management Drugs and Devices Market Outlook, By Other Applications (2014-2023) (US $MN)
39 Global Pain Management Drugs and Devices Market Outlook, By Indication (2014-2023) (US $MN)
40 Global Pain Management Drugs and Devices Market Outlook, By Arthritic Pain (2014-2023) (US $MN)
41 Global Pain Management Drugs and Devices Market Outlook, By Chronic back pain (2014-2023) (US $MN)
42 Global Pain Management Drugs and Devices Market Outlook, By Mode of Purchase (2014-2023) (US $MN)
43 Global Pain Management Drugs and Devices Market Outlook, By Over-the-Counter Devices (2014-2023) (US $MN)
44 Global Pain Management Drugs and Devices Market Outlook, By Prescription-Based Devices (2014-2023) (US $MN)
      

NOTE: Tables for North America, Europe, Asia Pacific, South America and Middle East & Africa are represented in the same manner above.  

1. What do I do if I have a query on this report?
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: [email protected] or phone: +1-301-202-5929
2. Is the sample available for this report? Can I request the sample with my specific requirements?
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
3. Format of the report?
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: [email protected] or phone: +1-301-202-5929
4. Services prior to purchase and after purchase?
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at [email protected] or call us on +1-301-202-5929.
5. License Type and Delivery?
We have 3 different licensing options available in electronic format.
  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment
6. Purchase procedure and Invoicing?
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards
7. Post sale support?
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at [email protected] or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.

Select License Type

Single User License (PDF)

 

2 - 5 User License (PDF)

 

Site License (PDF)

 

Corporate License (PDF)

 

Have a Question?


Know our Methodology

WHY CHOOSE US ?

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Adding more values to your product of interest.

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials